"University of Pittsburgh Asthma Institute is a pulmonologist located in Pittsburgh.Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, The University of Pittsburgh Asthma Institute at UPMC conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The University of Pittsburgh Asthma Institute at UPMC" #1 sponsor was "Sally E. Wenzel MD" with 2 trials, followed by "Array BioPharma" with 1 trials sponsored, "Gladwin, Mark, MD" with 1 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The University of Pittsburgh Asthma Institute at UPMC" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "The University of Pittsburgh Asthma Institute at UPMC" are "Asthma" (5 trials) and "H1N1 Influenza Virus" (1 trials). Many other conditions were trialed in "The University of Pittsburgh Asthma Institute at UPMC" in a lesser frequency.

Most popular intervention types in "The University of Pittsburgh Asthma Institute at UPMC" are "Drug" (5 trials), "Biological" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "ARRY-502, CRTh2 antagonist; oral" (1 trials), "CXA-10" (1 trials), "Conjugated Linolenic Acid" (1 trials) and "Dupilumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "The University of Pittsburgh Asthma Institute at UPMC" are 6 trials for "All" genders.

Currently, there are NaN active trials in "The University of Pittsburgh Asthma Institute at UPMC". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in The University of Pittsburgh Asthma Institute at UPMC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The University of Pittsburgh Asthma Institute at UPMC, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".